The utility of brain natriuretic peptide as a prognosticating marker in critical care patients
Article Sidebar
Main Article Content
Abstract
Background. Brain natriuretic peptide (BNP) is an established biomarker of morbidity and mortality in cardiac failure. Data also suggest potential prognostic utility in non-heart failure cohorts. The utility of BNP in predicting intensive care unit (ICU) outcomes has not been well evaluated in a mixed critical care population in the South African (SA) context.
Objective. To evaluate the ability of BNP to predict ICU mortality in a heterogeneous critical care population in SA.
Methods. This was a retrospective observational study of 100 patients admitted to a multidisciplinary, closed, intensivist-run ICU in a tertiary academic hospital serving KwaZulu-Natal Province (1 January 2020 - 31 July 2022). Initial BNP was evaluated as a predictor of ICU mortality using univariate and multivariable analyses.
Results. There was a statistically significant difference in BNP between survivors and non-survivors in the cohort of patients without heart failure. The median initial BNP in the non-heart failure cohort was 411 (interquartile range (IQR) 116 - 848) ng/L in non-survivors, and 150 (44 - 356) ng/L in survivors (p=0.028). The optimal cut-off for BNP was determined as 366 ng/L. A BNP ≥366 ng/L was an independent predictor of ICU outcome.
Conclusion. This study highlights the potential utility of BNP as a predictor of ICU mortality in a heterogeneous ICU population, with the greatest utility in patients without heart failure. Further studies are required to confirm this finding.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCC is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Nakagawa Y, Nishikimi T, Kuwahara K. Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides 2019;111:18-25. https://doi.org/10.1016/j.peptides.2018.05.012
Calzetta L, Orlandi A, Page C, et al. Brain natriuretic peptide: Much more than a biomarker. Int J Cardiol 2016;221:1031-1038. https://doi.org/10.1016/j.ijcard.2016.07.109
Mueller C, Maisel A, Mebazaa A, et al. The use of B-type natriuretic peptides in the intensive care unit. Congest Heart Fail 2008;14(4):43-45. https://doi.org/10.1111/j.1751-7133.2008.tb00011.x
Rodseth RN, Biccard BM, Manach YL, et al. The prognostic value of pre-operative and postoperative
B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide. A systematic review and individual patient data meta-analysis. J Am Coll Cardiol 2014;63(2):170-180. https://
doi.org/10.1016/j.jacc.2013.08.1630
Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol 2017;33(1):17-32. https://doi.org/10.1016/j.cjca.2016.09.008
Januzzi JL, Morss, Tung R, et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: A prospective cohort study. Crit Care 2006;10(1):37.https://doi.org/10.1186/cc4839
Papanikolaou J, Makris D, Mpaka M, et al. New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care 2014;18(3):94.https://doi.org/10.1186/cc13864
Doust J, Lehman R, Glasziou P. The role of BNP in heart failure. Am Fam Phys 2006;74(11):1893-1900.
Shang C. B-type natriuretic peptide-guided therapy for perioperative medicine? Open Heart 2014;1:e000105. https://doi.org/10.1136/openhrt-2014-000105
Wilhelms SB, Wilhelms DB. Emergency department admissions to the intensive care unit – a national retrospective study. BMC Emerg Med 2021;21:122. https://doi.org/10.1186/s12873-021-00517-0
Mullins PM, Goyal M, Pines J. National growth in intensive care unit admissions from emergency departments in the United States from 2002 to 2009. Acad Emerg Med 2013;20:479-486. https://doi.org/10.1111/acem.12134
De Vasconcellos K, Skinner DL. Hyperchloraemia is associated with acute kidney injury and mortality in the critically ill: A retrospective observational study in a multidisciplinary intensive care unit. J Crit Care 2018;1:45-51. https://doi.org/10.1016/j.jcrc.2018.01.019
Bachmann KN, Gupta DK, Xu M, et al. Unexpectedly low natriuretic peptide levels in patients with heart failure. J Am Coll Cardiol: Heart Failure 2021;9(3):192-200. https://doi.org/10.1016/j.jchf.2020.10.008
Sakane K, Kanzaki Y, Tsuda K, et al. Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction. Int J Cardiol 2020;327:105-110. https://doi.org/10.1016/j.ijcard.2020.11.066
Kakoullis L, Giannopoulou E, Papachristodoulou, et al. The utility of brain natriuretic peptides in septic shock as markers for mortality and cardiac dysfunction: A systematic review. Int J Clin Pract 2019;73(7):133-174. https://doi.org/10.1111/ijcp.13374
York MK, Gupta DK, Reynolds CF, et al. B-type natriuretic peptide levels and mortality in patients with and without heart failure. J Am Coll Cardiol 2018;71(19):2079-2088. https://doi.org/10.1016%2Fj.jacc.2018.02.071
Kandil E, Burack J, Sawas A, et al. B-type natriuretic peptide: A biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg 2008;43(3):242-246. https://doi.org/10.1001/archsurg.2007.69